2004 - Fellow of the American Academy of Arts and Sciences
1993 - Fellow of the American Association for the Advancement of Science (AAAS)
Jay A. Levy spends much of his time researching Virology, Virus, Immunology, Acquired immunodeficiency syndrome and Viral disease. He studies Viral replication which is a part of Virology. His work in Virus addresses subjects such as Antigen, which are connected to disciplines such as Cell type.
His work deals with themes such as Cytotoxic T cell and Disease, which intersect with Immunology. His research integrates issues of Transmission, Viral entry, Epidemiology and Cohort in his study of Acquired immunodeficiency syndrome. His Viral disease research incorporates themes from Immunofluorescence, Serology, Seroconversion and Immunopathology.
Jay A. Levy mostly deals with Virology, Virus, Immunology, Acquired immunodeficiency syndrome and Antibody. Jay A. Levy is studying Viral replication, which is a component of Virology. His Virus research incorporates elements of Molecular biology, Serology and Antigen.
Jay A. Levy frequently studies issues relating to Disease and Immunology. His biological study spans a wide range of topics, including Transmission, Seroconversion and Gerontology. His CD8 study combines topics from a wide range of disciplines, such as Cytotoxic T cell, T lymphocyte and T cell.
His scientific interests lie mostly in Virology, Immunology, Immune system, Acquired immunodeficiency syndrome and Virus. His specific area of interest is Virology, where he studies Viral replication. He studied Viral replication and Molecular biology that intersect with RNA.
His study in Immunology focuses on Viral load, Antibody, Lentivirus, Viral disease and T cell. His Immune system research is multidisciplinary, relying on both HIV vaccine and Pathogen. His research in Acquired immunodeficiency syndrome intersects with topics in Innate immune system, Clinical trial, Disease and Immunopathology.
His main research concerns Immunology, Virology, Immune system, Virus and Acquired immunodeficiency syndrome. Jay A. Levy combines topics linked to Cell with his work on Immunology. His studies in Virology integrate themes in fields like Chemokine receptor CCR5, Innate immune system and Pathogenesis.
The concepts of his Immune system study are interwoven with issues in Epithelium, Oral epithelia and Ex vivo. His Virus research is multidisciplinary, incorporating elements of Glutamine and Intestinal mucosa. His Acquired immunodeficiency syndrome study integrates concerns from other disciplines, such as Viral disease and Immunopathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS
Jay A. Levy;Anthony D. Hoffman;Susan M. Kramer;Jill A. Landis.
Science (1984)
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Pereyra F;Jia X;McLaren Pj.
Science (2010)
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication
Christopher M. Walker;Dewey J. Moody;Daniel P. Stites;Jay A. Levy.
Science (1986)
Pathogenesis of human immunodeficiency virus infection.
J A Levy.
Microbiological Research (1993)
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2)
Ray Sanchez-Pescador;Michael D. Power;Philip J. Barr;Kathelyn S. Steimer.
Science (1985)
Biologic features of HIV-1 that correlate with virulence in the host
Cecilia Cheng-Mayer;Deborah Seto;Masatoshi Tateno;Jay A. Levy.
Science (1988)
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.
Steven G. Deeks;Christina M. R. Kitchen;Lea Liu;Hua Guo.
Blood (2004)
Human immunodeficiency viruses.
John Coffin;Ashley Haase;Jay A. Levy;Luc Montagnier.
Science (1986)
Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene.
Tatsuo Shioda;Jay A. Levy;Cecilia Cheng-Mayer.
Nature (1991)
Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients
John A. Ambroziak;David J. Blackbourn;Brian G. Herndier;Richard G Glogau.
Science (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Aaron Diamond AIDS Research Center
University of California, San Francisco
King's College London
University of California, Davis
University of California, San Francisco
University of California, San Diego
University of California, San Francisco
Rush University Medical Center
Bill & Melinda Gates Foundation
Oregon Health & Science University
KTH Royal Institute of Technology
Dalian Maritime University
University of Minnesota
Centre national de la recherche scientifique, CNRS
Pfizer (United States)
University of Copenhagen
University of Edinburgh
Bionics Institute
University of Science and Technology of China
Aix-Marseille University
Boston University
Yale University
Harvard University
Johns Hopkins University
University of Giessen
Griffith University